EE03919B1 - Asendatud fenüülamidiinid, neid ühendeid sisaldavad ravimid ja meetod nende valmistamiseks - Google Patents
Asendatud fenüülamidiinid, neid ühendeid sisaldavad ravimid ja meetod nende valmistamiseksInfo
- Publication number
- EE03919B1 EE03919B1 EE9700292A EE9700292A EE03919B1 EE 03919 B1 EE03919 B1 EE 03919B1 EE 9700292 A EE9700292 A EE 9700292A EE 9700292 A EE9700292 A EE 9700292A EE 03919 B1 EE03919 B1 EE 03919B1
- Authority
- EE
- Estonia
- Prior art keywords
- pct
- compounds
- preparation
- drugs containing
- sec
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19515500A DE19515500A1 (de) | 1995-04-27 | 1995-04-27 | Substituierte Phenylamidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
PCT/EP1996/001615 WO1996033970A1 (de) | 1995-04-27 | 1996-04-18 | Substituierte phenylamidine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
Publications (2)
Publication Number | Publication Date |
---|---|
EE9700292A EE9700292A (et) | 1998-06-15 |
EE03919B1 true EE03919B1 (et) | 2002-12-16 |
Family
ID=7760507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EE9700292A EE03919B1 (et) | 1995-04-27 | 1996-04-18 | Asendatud fenüülamidiinid, neid ühendeid sisaldavad ravimid ja meetod nende valmistamiseks |
Country Status (24)
Country | Link |
---|---|
US (1) | US5958952A (et) |
EP (1) | EP0824515B1 (et) |
JP (1) | JPH11504630A (et) |
KR (1) | KR19990008011A (et) |
AT (1) | ATE200277T1 (et) |
AU (1) | AU703946B2 (et) |
BG (1) | BG63385B1 (et) |
BR (1) | BR9608038A (et) |
CA (1) | CA2219337A1 (et) |
CZ (1) | CZ288764B6 (et) |
DE (2) | DE19515500A1 (et) |
DK (1) | DK0824515T3 (et) |
EE (1) | EE03919B1 (et) |
ES (1) | ES2158309T3 (et) |
GR (1) | GR3036023T3 (et) |
HU (1) | HU222050B1 (et) |
NO (1) | NO309422B1 (et) |
NZ (1) | NZ306451A (et) |
PL (1) | PL184276B1 (et) |
PT (1) | PT824515E (et) |
RU (1) | RU2167857C2 (et) |
SK (1) | SK282232B6 (et) |
TR (1) | TR199701258T1 (et) |
WO (1) | WO1996033970A1 (et) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU691361B2 (en) * | 1994-12-01 | 1998-05-14 | Toyama Chemical Co. Ltd. | Novel 2,3-diketopiperazine derivative or salt thereof |
US5942544A (en) * | 1996-02-22 | 1999-08-24 | Dupont Pharmaceuticals Company | α-branched anilines, toluenes, and analogs thereof as factor Xa inhibitors |
DE19833105A1 (de) * | 1998-07-23 | 2000-01-27 | Boehringer Ingelheim Pharma | Substituierte Phenylamidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
US6242466B1 (en) * | 1998-07-23 | 2001-06-05 | Boehringer Ingelheim Pharma Kg | Substituted phenylamidines |
DE10002510A1 (de) * | 2000-01-21 | 2001-07-26 | Boehringer Ingelheim Pharma | Substituierte Phenylamidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5084466A (en) * | 1989-01-31 | 1992-01-28 | Hoffmann-La Roche Inc. | Novel carboxamide pyridine compounds which have useful pharmaceutical utility |
US5256812A (en) * | 1989-01-31 | 1993-10-26 | Hoffmann-La Roche Inc. | Carboxamides and sulfonamides |
DE4035961A1 (de) * | 1990-11-02 | 1992-05-07 | Thomae Gmbh Dr K | Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
DE4127404A1 (de) * | 1991-08-19 | 1993-02-25 | Thomae Gmbh Dr K | Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
US5254573A (en) * | 1991-10-15 | 1993-10-19 | Monsanto Company | Substituted heterocyclic derivatives useful as platelet aggregation inhibitors |
JPH07500335A (ja) * | 1991-10-15 | 1995-01-12 | モンサント カンパニー | 血小板凝集抑制剤として有用な置換複素環誘導体 |
-
1995
- 1995-04-27 DE DE19515500A patent/DE19515500A1/de not_active Withdrawn
-
1996
- 1996-04-18 CZ CZ19973406A patent/CZ288764B6/cs not_active IP Right Cessation
- 1996-04-18 AU AU55008/96A patent/AU703946B2/en not_active Ceased
- 1996-04-18 DK DK96912018T patent/DK0824515T3/da active
- 1996-04-18 DE DE59606725T patent/DE59606725D1/de not_active Expired - Fee Related
- 1996-04-18 EE EE9700292A patent/EE03919B1/et not_active IP Right Cessation
- 1996-04-18 HU HU9801228A patent/HU222050B1/hu not_active IP Right Cessation
- 1996-04-18 PL PL96322969A patent/PL184276B1/pl unknown
- 1996-04-18 WO PCT/EP1996/001615 patent/WO1996033970A1/de not_active Application Discontinuation
- 1996-04-18 JP JP8532141A patent/JPH11504630A/ja not_active Ceased
- 1996-04-18 EP EP96912018A patent/EP0824515B1/de not_active Expired - Lifetime
- 1996-04-18 TR TR97/01258T patent/TR199701258T1/xx unknown
- 1996-04-18 PT PT96912018T patent/PT824515E/pt unknown
- 1996-04-18 RU RU97119520/04A patent/RU2167857C2/ru active
- 1996-04-18 KR KR1019970707535A patent/KR19990008011A/ko not_active Application Discontinuation
- 1996-04-18 SK SK1443-97A patent/SK282232B6/sk unknown
- 1996-04-18 ES ES96912018T patent/ES2158309T3/es not_active Expired - Lifetime
- 1996-04-18 NZ NZ306451A patent/NZ306451A/en unknown
- 1996-04-18 AT AT96912018T patent/ATE200277T1/de not_active IP Right Cessation
- 1996-04-18 US US08/945,611 patent/US5958952A/en not_active Expired - Lifetime
- 1996-04-18 BR BR9608038A patent/BR9608038A/pt not_active Application Discontinuation
- 1996-04-18 CA CA002219337A patent/CA2219337A1/en not_active Abandoned
-
1997
- 1997-10-20 BG BG101983A patent/BG63385B1/bg unknown
- 1997-10-24 NO NO974945A patent/NO309422B1/no not_active IP Right Cessation
-
2001
- 2001-06-13 GR GR20010400876T patent/GR3036023T3/el not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO933248L (no) | Cykliske urinstoffderivater, legemidler inneholdende disse forbindelser, og fremgangsmåte for deres fremstilling | |
EA200300671A1 (ru) | Производные хиназолина, содержащие эти соединения лекарственные средства, их применение и способ их получения | |
MX9803954A (es) | Derivados de aminoacidos, composiciones farmaceuticas que contienen estos compuestos y procesos para prepararlos. | |
NO984084L (no) | 4-Amino-pyrimidin-derivater, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmÕte ved fremstilling derav | |
NO934501L (no) | Karboksylsyrederivater, legemidler inneholdende disse forbindelser, og fremgangsmåte for deres fremstilling | |
ATE279406T1 (de) | Piperidinderivate mit tachykinin-antagonistischer wirkung | |
NO940261L (no) | 5-leddete heterocykler, fremgangsmåte ved fremstilling derav og legemidler som inneholder disse forbindelser | |
EE9700211A (et) | Pürimido[5,4-d]pürimidiinid, neid ühendeid sisaldavad ravimid, nende kasutamine ja meetod nende valmistamiseks | |
ATE195117T1 (de) | 1-amdinophenyl-pyrrolidone/piperidinone als blutblättchen-aggregations inhibitoren | |
NO972881L (no) | Piperazinderivater, legemidler som inneholder disse, anvendelse derav og fremgangsmåte for deres fremstilling | |
YU50002A (sh) | Supstituisani piperidini, lekovi koji sadrže ova jedinjenja i postupci za njihovu proizvodnju | |
YU30902A (sh) | Novi ciklopropani kao cgrp antagonisti, lekovi koji sadrže navedena jedinjenja i postupak za njihovu proizvodnju | |
FI973221A0 (fi) | 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina | |
MX9302459A (es) | Derivados imino ciclicos, medicamentos que contienen estos compuestos y procedimientos para su preparacion. | |
EE03919B1 (et) | Asendatud fenüülamidiinid, neid ühendeid sisaldavad ravimid ja meetod nende valmistamiseks | |
NO981970L (no) | FremgangsmÕte for fremstilling av Camptothecin-derivater | |
BR9610175A (pt) | Composto processo de preparação do composto composição farmacêutica e utilização do composto | |
ATE273979T1 (de) | Xanthinderivate, zwischenprodukte und verwendung zur behandlung von osteoporosis | |
YU3701A (sh) | Supstituisani fenilamidini sa antitrombskim dejstvom | |
FR2700165B1 (fr) | Dérivés de pyrrolidine, leur préparation et les médicaments les contenant. | |
ATE190316T1 (de) | Peptid-aldehydderivate als antikoagulierende mittel | |
ES2150149T3 (es) | Derivados de 17-beta-(2-oxo-tetrahidrofuran-4-il)-tio-androstano (tioderivados de 17-beta-(lactona del acido gamma-butirico)) para el tratamiento de la inflamacion, composiciones farmaceuticas y un procedimiento para la produccion de los mismos. | |
NO974197L (no) | Fremgangsmåte til fremstilling av estere av anhydroecgonin | |
MX9803556A (es) | Derivados de aminoacidos, medicamentos que contienen tales compuestos y metodos para producirlos. | |
MX9803557A (es) | Derivados de aminoacidos, medicamentos que contienen tales compuestos y metodos para producir tales compuestos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB4A | Valid patent at the end of a year |
Effective date: 20021231 |
|
MM4A | Lapsed by not paying the annual fees |
Effective date: 20030418 |